SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

NVAX RSS Feed
Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, beambe
Search This Board: 
Last Post: 9/21/2017 11:32:50 AM - Followers: 217 - Board type: Free - Posts Today: 0

ABOUT NOVAVAX:

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.
 


MANAGEMENT TEAM:

President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.

 

CLINICAL-STAGE PIPELINE:

Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.

 
ADJUVANT PIPELINE:

 

 
CHARTS:



 


LINKS:

http://www.novavax.com/
http://finance.yahoo.com/q/h?s=NVAX
http://www.novavax.com/download/File/Interphex.pdf
http://www.sec.gov/cgi-bin/browse-edgar?company=Novavax&CIK=&filenum=&State=&SIC=&owner=include&action=getcompany
http://www.wipo.int/pctdb/en/wo.jsp?WO=2008061243

 
SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
NVAX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVAX News: Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference 09/19/2017 04:05:28 PM
NVAX News: Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference 09/19/2017 04:05:00 PM
NVAX News: Novavax Initiates Phase 1/2 Trial of NanoFlu(TM) Vaccine in Older Adults 09/19/2017 09:05:37 AM
NVAX News: Novavax Initiates Phase 1/2 Trial of NanoFlu™ Vaccine in Older Adults 09/19/2017 09:05:00 AM
NVAX News: Amended Statement of Ownership (sc 13g/a) 09/11/2017 11:27:35 AM
PostSubject
#4823   Alot of buying at ask today, usually between don estaban 09/21/17 11:32:50 AM
#4822   Where we going? Seems to have trouble moving up don estaban 09/19/17 05:40:15 PM
#4821   The bottom line is that, at least in bleu22 09/19/17 05:09:34 PM
#4820   NVAX NEWS OUT TRIALS BEGINNING https://finance.yahoo.com/news/novavax-initiates imapro 09/19/17 12:57:04 PM
#4819   NVAX bleu22 09/19/17 10:16:33 AM
#4818   Huge need with NCAA and GNCA bleu22 09/19/17 10:13:25 AM
#4817   Probably NOT until tissues start filling up with snot Scotttrader80 09/19/17 10:04:39 AM
#4816   News should start coming bleu22 09/19/17 09:32:06 AM
#4815   Think its going under $1? don estaban 09/18/17 07:44:31 PM
#4814   NVAX is doing that all on its own Scotttrader80 09/18/17 07:17:19 PM
#4813   They are just covering @ will, we need bleu22 09/18/17 04:44:54 PM
#4812   Shorts pulling the price down ? don estaban 09/18/17 03:34:00 PM
#4811   Wow NVAX is stagnant but its not cold Scotttrader80 09/18/17 01:46:41 PM
#4810   https://news.medgenera.com/10-vaccine-development-2017-top-vaccine-2017/ bleu22 09/18/17 08:16:19 AM
#4809   I have a feeling, we start moving up bleu22 09/17/17 05:18:07 PM
#4808   Juice Newton 09/16/17 12:33:26 PM
#4807   Closing buy of 2+ MLL and many large the gipper 09/16/17 11:18:43 AM
#4806   Could there be one or more "seamless" clinical north40000 09/15/17 11:23:13 AM
#4805   None of my September 15 $1 Calls were WovenOxygen 09/15/17 02:35:27 AM
#4804   NVAX $1.22 hit, BLAST OFF IMMINENT imapro 09/14/17 10:06:33 AM
#4803   NICE bleu22 09/13/17 06:51:34 PM
#4802   NVAX NEWS John Engle Novavax: Catalysts Building Toward A imapro 09/13/17 01:13:18 PM
#4801   Yes sir. WovenOxygen 09/13/17 12:55:23 PM
#4800   Bid building bleu22 09/12/17 11:59:07 AM
#4799   Never know, they could b picking up options bleu22 09/12/17 11:19:00 AM
#4798   They are probably kicking themselves for selling as Alyssa 09/12/17 11:17:02 AM
#4797   the party in question sold enough of their Atlanta1 09/11/17 03:49:14 PM
#4796   Atlanta1, thank you. I guess I'm still Dgoff 09/11/17 03:44:53 PM
#4795   Item 5. Ownership of Five Percent or Less Atlanta1 09/11/17 12:46:13 PM
#4794   Not seeing any big news or am I blind Dgoff 09/11/17 12:42:21 PM
#4793   Disposable WovenOxygen 09/11/17 12:33:06 PM
#4792   I think you had better read the filing Atlanta1 09/11/17 12:30:06 PM
#4791   12% increase i shares bought don estaban 09/11/17 12:18:54 PM
#4790   Huge news! http://www.nasdaq.com/quotes/institutional-portfolio/fmr-lll-12407 WovenOxygen 09/11/17 12:09:36 PM
#4789   Same to u, news soon, hopefully better next week. bleu22 09/08/17 05:43:03 PM
#4788   :-) What a day huh!?! Enjoy WovenOxygen 09/08/17 03:45:20 PM
#4787   9:12:25 bleu22 09/08/17 10:14:44 AM
#4786   9:22:25 191,118 nice buy bleu22 09/08/17 10:14:15 AM
#4785   Nice volume, and nice close. bleu22 09/07/17 07:13:42 PM
#4784   I agree Alyssa. I might go to WovenOxygen 09/07/17 04:17:48 PM
#4783   There has been a slow and steady move Alyssa 09/07/17 04:00:33 PM
#4782   Good to see some new blood here today! WovenOxygen 09/07/17 03:13:57 PM
#4781   Lets hope but think the whole sector is don estaban 09/07/17 02:43:07 PM
#4780   Something cooking :) Santo 09/07/17 02:41:26 PM
#4779   Bought some more today, let's see this thing imapro 09/07/17 12:48:32 PM
#4778   Bcrx got a upgrade by jeffries so maybe don estaban 09/07/17 12:47:38 PM
#4777   Novavax will be participating in the 12th annual imapro 09/07/17 12:07:26 PM
#4776   I'm liking what I see here imapro 09/07/17 11:54:38 AM
#4775   In @1.09 let's goooo imapro 09/06/17 04:25:02 PM
#4774   Nice bids !!! don estaban 09/06/17 03:18:18 PM
PostSubject